An international committee of leading nutrition scientists from 10 countries on three continents has released a consensus statement that concludes that carbohydrate quality (measured by the glycemic index or GI) matters and that the carbohydrates present in different foods affect post-meal blood sugar differently, with important health implications.
The recall was initiated because the infusion sets have the potential to cause over- or under-delivery of insulin, which could result in low or high blood glucose levels.
This is a big month for people with diabetes who are enrolled in Medicare. The giant government healthcare program for seniors is changing its method for providing blood glucose testing supplies.
People with impaired glucose tolerance – the precursor to Type 2 diabetes – often show impaired cognitive function that may be alleviated through a diet designed specifically for their condition
A study published in 2009 looked at one type of mogroside called mogroside V, and found it to be a low-glycemic-index sweetener with a positive effect on stimulating insulin secretion.
Experts from across the globe spoke as part of an American Diabetes Association program, bringing to light some of the key concerns for those managing hypoglycemia in diabetes patients.
While there is still no cure for diabetes, there is a growing number of therapies available to those battling the disease-and even more are in the works, according to experts who spoke at a recent symposium.
In 2 phase 3 trials examining the concept of triweekly dosing with the long-acting insulin degludec (Tresiba, Novo Nordisk) in patients with type 2 diabetes, the recipients had inferior glucose control and an increased risk for hypoglycemia.
As you may have heard, some Diabetes Online Community (DOC) advocates have started a social media campaign calling for better accuracy requirements on blood sugar meters and strips.
Right now, the tiny needles that poke our fingers for blood sugar tests are one of the few diabetes supplies not scrutinized by FDA, which makes it easy for us to get them by the box-load without much hassle. But that may soon be changing.
Dual achievement of both glycated hemoglobin and low-density lipoprotein cholesterol goals among patients with diabetes is associated with greater clinical and economic benefit than achievement of either goal alone, according to a study published online June 25 in Diabetes Care.
In this video, health-care analysts David Williamson and Max Macaluso discuss the cutting edge of insulin treatments, including a new inhalable insulin in development by MannKind.
Good nut news! A new study showed that eating peanuts or peanut butter with breakfast limited the rise in blood glucose after both breakfast and lunch. This “second-meal” effect was completely unexpected and exciting.
Last week, 17,000 diabetes doctors and other professionals gathered at the American Diabetes Association’s 73rd Scientific Sessions. This is where the greatest minds in diabetes come to share research and debate the best path forward. Today, we are sharing highlights from the conference.
Overweight patients with diabetes or impaired glucose tolerance who had moderate glycemic levels prior to starting a short-term workout program achieved better glycemic control than those with higher glycemic levels at baseline, researchers found.
For obese adults who do not use non-nutritive sweetener (NNS), sucralose affects the glycemic and insulin responses to an oral glucose load, according to a study published online April 30 in Diabetes Care.
People have differing abilities to release and react to insulin depending on ethnicity, according to a new study from researchers at Lund University in Sweden, Stanford University and Kitasato University.
We have choices. Whether it’s the latest gadgets like glucose meters, insulin pumps, or continuous glucose monitors (CGMs), or different types of medications, options exist and we are fortunate enough right now to be able to tailor our D-Lives how we’d like in many respects.
Almost two decades after the landmark Diabetes Control and Complications Trial (DCCT) ended, we are still seeing dramatic reductions in diabetes complications achieved with intensive glycemic control in the intensive control group.
Serious hypoglycemia (low blood glucose) is still prevalent in the United States. One-third of people with diabetes currently use insulin, and roughly 90% of those who use insulin have experienced hypoglycemia.